As FoxP3+ Treg cells are known to suppress anti-tumor immunity in NSCLC (50), these findings suggested that IL-9 derived from Treg cells and TIL might control immune responses and tumor growth. The gene discussed is IL9; the disease is non-small cell lung carcinoma.